Repetitive nerve stimulation vs. twitch tension in rats with EAMG

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Muscle and Nerve

• Publication date

  1992-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mus.880150116PMID 1732768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single‐fiber electromyography in experimental autoimmune myasthenia gravis

  1990cited by this paper
• T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function.

  1990cited by this paper
• AAEE minimonograph #33: Electrodiagnostic approach to defects of neuromuscular transmission

  1989cited by this paper
• Clonotypic analysis of anti-acetylcholine receptor antibodies produced against native and denatured antigen.

  1989cited by this paper
• Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.

  1989cited by this paper
• Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.

  1988cited by this paper
• Influence of T cell specificity on the heterogeneity and disease-causing capability of antibody against the acetylcholine receptor.

  1987cited by this paper
• Analysis of contractile properties of muscles from rats immunized with purified acetylcholine receptor.

  1987cited by this paper
• Selective in vitro inhibition of an antibody response to purified acetylcholine receptor by using antigen-ricin A chain immunotoxin.

  1985cited by this paper
• Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.

  1985cited by this paper
• Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.

  1985cited by this paper
• Pre‐and post‐junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat.

  1984cited by this paper
• Curare can open and block ionic channels associated with cholinergic receptors

  1982cited by this paper
• Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.

  1982cited by this paper
• The laboratory diagnosis of mild myasthenia gravis

  1982cited by this paper
• α‐Bungarotoxin binding to the nicotinic acetylcholine receptor is inhibited by two distinct subpopulations of anti‐receptor antibodies

  1982cited by this paper
• Electrophysiological and clinical correlation in myasthenia gravis

  1982cited by this paper
• The biology of myasthenia gravis.

  1981cited by this paper
• Immunology of acetylcholine receptors in relation to myasthenia gravis.

  1980cited by this paper
• Suppression of tumor rejection by autologous anti-idiotypic immunity.

  1980cited by this paper
• Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin.

  1980cited by this paper
• Biology of myasthenia gravis.

  1980cited by this paper
• Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.

  1978cited by this paper
• Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis

  1978cited by this paper
• Modulation of acetylcholine receptor by antibody against the receptor.

  1977cited by this paper
• Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model

  1977cited by this paper
• DIAGNOSIS OF MYASTHENIA GRAVIS BY NERVE STIMULATION *

  1976cited by this paper
• EXPERIMENTAL AUTOIMMUNE MYASTHENIA: CLINICAL, NEUROPHYSIOLOGIC, AND PHARMACOLOGIC ASPECTS *

  1976cited by this paper
• THE RESULTS TO BE EXPECTED FROM ELECTRICAL TESTING IN THE DIAGNOSIS OF MYASTHENIA GRAVIS *

  1976cited by this paper

• Myasthenia Gravis: Unravelling the ATP role on neuromuscular transmission

  2016cites this paper
• Repetitive nerve stimulation often fails to detect abnormal decrement in acute severe generalized Myasthenia Gravis.

  2016cites this paper
• Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs

  2015cites this paper
• Changes in Acetylcholine Receptors and Functional Characterization in Muscle by TOF Stimulation in Rat Experimental Autoimmune Myasthenia Gravis (EAMG) Model

  2007cites this paper
• Muscle-derived nitric oxide synthase expression, differences associated with muscle fiber-type, and disease susceptibility in a rat model of myasthenia gravis.

  2006cites this paper
• Short-circuiting autoimmune disease by target-tissue-derived nitric oxide.

  2004cites this paper
• Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis.

  2003cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Neonatal tolerance to an immunodominant T cell reactivity does not confer resistance to EAMG induction in Lewis rats.

  1995cites this paper
• Examination of characteristics that may distinguish disease-causing from benign AChR-reactive antibodies in experimental autoimmune myasthenia gravis.

  1994cites this paper
• Immunological factors that influence disease severity in experimental autoimmune myasthenia gravis

  1994cites this paper
• Experimental Autoimmune Myasthenia Gravis

  1994cites this paper
• Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice.

  1994cites this paper
• Ca-tension relationships of muscle fibers from patients with periodic paralysis.

  1993cites this paper
• Erratum

  1993cites this paper
• Influence of Immunological Fine‐specificity on the Induction of Experimental Myasthenia Gravis a

  1993cites this paper